Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7119 p597
October 21, 2000 Clinical

Effects of paracetamol pack size restriction on overdose

The amount of paracetamol taken in single overdoses has been reduced by the introduction of pack size restrictions, pharmacist-led research has found.
In a study published in the British Medical Journal (2000;321:926), Mrs Denise Robinson (senior pharmacist, regional medicines and poisons information unit, the Royal hospitals, Belfast) and colleagues assessed the impact of reduced availability of paracetamol on the number and severity of overdoses. The study compared cases of self-poisoning in two six-month periods, one before pack size restrictions were introduced (in September, 1998) and the second period three months afterwards. It included 590 cases in the first group and 594 in the second.
The researchers found that the estimated quantity of paracetamol ingested fell from 10g in the first period to 8g in the second. These estimates were associated with a reduction in paracetamol concentration measurements four to six hours after the time of poisoning — 37mg/L in the first group compared with 27g/L in the second group. The percentage of patients given an antidote was also lower in the second group (25 per cent compared with 31 per cent). There was no change in the concentration of liver enzymes or the international normalised ratio at 24 to 48 hours after poisoning.
The researchers comment that overdose behaviour changed after the introduction of smaller blister packs of paracetamol. The quantity of paracetamol ingested was reduced and, although there was no change in liver function tests, this could be explained by early use of antidotes. Pack size restrictions had resulted in fewer antidotes being given and there were fewer hospital admissions. Both resulted in a reduction in costs, they say.